Murphy & Mullick Capital Management’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
VPM
VCM
KBG
PMG
Murphy & Mullick Capital Management's OGN Position: Q1 2026 in Review
Murphy & Mullick Capital Management sold out of Organon & Co (OGN) in Q1 2026, closing a stake of 199 shares — an estimated $1.43K sold.
Murphy & Mullick Capital Management first reported a position in OGN in Q4 2024 and held it in 5 quarters. The position peaked at $3.12K in Q4 2024. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.
- Murphy & Mullick Capital Management reported no remaining Organon & Co position as of Q1 2026 after selling out during the quarter.
- Murphy & Mullick Capital Management sold 199 Organon & Co shares in Q1 2026, an estimated $1.43K.
- Murphy & Mullick Capital Management first reported a position in Organon & Co in Q4 2024 and held it in 5 quarters.
- Murphy & Mullick Capital Management's Organon & Co position peaked at $3.12K in Q4 2024.
- 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.
Based on Murphy & Mullick Capital Management's 13F filing for Q1 2026, filed 17 Apr 2026.